Background Obstructive sleep apnoea (OSA) and narcolepsy are estimated to affect approximately 4.8% and 0.047% of the UK population, respectively. We do not know how many people have been diagnosed or ...

ROCKVILLE, Md., Feb. 3, 2026 /PRNewswire/ -- EXCEL Services Corporation announced today that it is supporting North Dakota's state-funded advanced nuclear energy study through focused analysis of ...

2 NHC Key Lab of Health Economics and Policy Research (Shandong University), Jinan, China Background The special nature of the functional ability of older individuals with disabilities places higher ...

Power Query used to be quite limited in Excel for the web, but Microsoft has now rolled out an update that brings the full experience to certain subscribers. Microsoft, in a recent announcement, said ...

The original version of this story appeared in Quanta Magazine. All of modern mathematics is built on the foundation of set theory, the study of how to organize abstract collections of objects. But in ...

The brain goes through five distinct stages between birth and death, a new study shows. Scientists identified the average ages—9, 32, 66 and 83—when the pattern of connections inside our brains shift.

Objectives The objective of this study was to assess the palliative care needs of patients with neurological conditions through the application of the Supportive and Palliative Care Indicators Tool ...

As we age, the human brain rewires itself. The process happens in distinct phases, or “epochs,” according to new research, as the structure of our neural networks changes and our brains reconfigure ...

Descriptive set theorists study the niche mathematics of infinity. Now, they’ve shown that their problems can be rewritten in the concrete language of algorithms. All of modern mathematics is built on ...

Artificial intelligence agents powered by the world's most advanced language models routinely fail to complete even straightforward professional tasks on their own, according to groundbreaking ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...